Boston Scientific continues to expect Penumbra closing by year-end
By Flavia Fortes and Curtis Eichelberger ( July 29, 2026, 15:42 GMT | Insight) -- Boston Scientific said it continues to expect its acquisition of Penumbra to close in the second half of 2026, subject to receipt of the remaining regulatory clearances. Boston Scientific executives reaffirmed their previously disclosed closing timeline in a call with investors Wednesday. Boston Scientific said it continues to expect its acquisition of Penumbra to close in the second half of 2026, subject to receipt of the remaining regulatory clearances. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.